Monroe Capital LLC announced an increase in its credit facility to ProPharma Group (ProPharma) to support the acquisition of Xendo Holding B.V. (Xendo). ProPharma is an existing portfolio company of Linden Capital Partners.
 
Based in the Netherlands, Xendo is a provider of compliance consulting, engineering & technical support, regulatory affairs, and pharmacovigilance services to the (bio)pharmaceutical, medical device and healthcare industries. This acquisition expands ProPharma’s geographic coverage for compliance consulting services to include Europe and adds additional high-value regulatory affairs and pharmacovigilance services making ProPharma a single-source, global independent provider of compliance, regulatory affairs, pharmacovigilance, and medical information solutions.